- Would mark one of the biggest private credit deals this year
- Transaction is for refinancing debt and a new term loan
Blue Owl Capital Inc. is leading a private credit transaction of roughly $4 billion for PCI Pharma Services, according to people with knowledge of the matter, in what would be one of the largest direct lending deals of the year.
The transaction includes an approximately $3 billion unitranche loan that would refinance the company’s existing debt, the people said, asking not to be named discussing a private transaction. In addition, lenders are in discussions to provide a delayed-draw term loan of more than $1 billion, though the size could still change, they said.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.